RXRX Recursion Pharmaceuticals Inc

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Recursion Pharmaceuticals,

Inc. (the Company), hereby constitutes and appoints Nathan Hatfield, Kyle

Nelson, and Jonathan Golightly, each, the undersigned's true and lawful

attorney-in-fact to:

1. Complete and execute Forms ID, 3, 4 and 5 and other forms and all

amendments thereto as such attorney-in-fact shall in his or her discretion

determine to be required or advisable pursuant to Section 16 of the Securities

Exchange Act of 1934 (as amended) and the rules and regulations promulgated

thereunder, or any successor laws and regulations, as a consequence of the

undersigned's ownership, acquisition or disposition of securities of the

Company; and

2. Do all acts necessary in order to file such forms with the Securities and

Exchange Commission, any securities exchange or national association, the

Company and such other person or agency as the attorney-in-fact shall deem

appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact

and agents shall do or cause to be done by virtue hereof.  The undersigned

acknowledges that the foregoing attorneys-in-fact, in serving in such

capacity at the request of the undersigned, are not assuming, nor is the

Company assuming, any of the undersigned's responsibilities to comply with

Section 16 of the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect

to the undersigned's holdings of and transactions in securities issued by

the Company, unless earlier revoked by the undersigned in a signed writing

delivered to the Company and the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney

to be executed as of November 22, 2024.

Signature:

/s/ Ben R. Taylor

Ben R. Taylor

-0-

Normal.dotm

Recursion Pharmaceuticals (NASDAQ:RXRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Recursion Pharmaceuticals (NASDAQ:RXRX)
Historical Stock Chart
From Jan 2024 to Jan 2025